Schedule 13G ownership disclosure

EYEPOINT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 30233G100

Event date: 2020-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000038777-20-000180
Form type
SC 13G
Filer
EyePoint, Inc.
CIK
CIK 1314102
Filed
Nov 10, 2020
Reporting period
Oct 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub